IP Library Granted Patent US 7,968,310
Granted Patent B2
US 7,968,310 · App. 12/162,952 · Granted Jun 28, 2011

Tagged sialyltransferase proteins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,968,310
App. No.
12/162,952
Granted
Jun 28, 2011
Kind
B2
Abstract

The present invention provides modified Campylobacter sialyltransferase proteins that exhibit enhanced expression as compared to its unmodified form. Nucleic acids that encode the sialyltransferase proteins are also included, as are methods to produce and use the sialyltransferase proteins.

Claims (10)

1. A tagged sialyltransferase protein comprising a sialyltransferase polypeptide, wherein the sialyltransferase polypeptide comprises an amino acid sequence with at least 95% amino acid sequence identity to SEQ ID NO: 4, wherein the sialyltransferase polypeptide has a methionine-glycine-serine (MGS) tag at the amino terminus, and wherein the tagged sialyltransferase protein has sialyltransferase activity.

2. The tagged sialyltransferase protein of claim 1 , wherein the sialyltransferase polypeptide is truncated.

3. The tagged sialyltransferase of claim 1 , wherein the sialyltransferase polypeptide is SEQ ID NO: 4.

4. The tagged sialyltransferase protein of claim 1 , wherein the protein begins with a mixture of methionine, glycine or serine.

5. A tagged sialyltransferase protein comprising a sialyltransferase polypeptide, wherein the sialyltransferase polypeptide comprises an amino acid sequence with at least 95% amino acid sequence identity to SEQ ID NO:4, wherein the sialyltransferase polypeptide has a methionine-glycine-serine (MGS) tag at the amino terminus, wherein the sialyltransferase polypeptide comprises sialyltransferase motif A (SEQ ID NO: 11) and sialyltransferase motif B (SEQ ID NO: 12), and wherein the tagged sialyltransferase protein has sialyltransferase activity.

6. A method of producing a sialylated oligosaccharide product comprising:

a) contacting an acceptor substrate comprising an oligosaccharide with the tagged sialyltransferase of claim 1 , and with a donor substrate comprising a sialic acid moiety; and

b) allowing transfer of the sialic acid moiety from the donor substrate to the acceptor substrate, thereby producing the sialylated oligosaccharide product.

7. The method of claim 6 , wherein the sialylated oligosaccharide product is produced in vitro.

8. The method of claim 6 , wherein the sialylated oligosaccharide product is produced in vivo.

Assignments (6)
ADDRESS CHANGE Recorded Apr 22, 2014
From: BIOGENERIX AG
To: BIOGENERIX AG
Reel/Frame 032734/0829 →
MERGER Recorded Apr 22, 2014
From: BIOGENERIX GMBH
To: RATIOPHARM GMBH
Reel/Frame 032735/0296 →
CHANGE OF NAME Recorded Apr 22, 2014
From: BIOGENERIX AG
To: BIOGENERIX GMBH
Reel/Frame 032743/0923 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2011
From: NOVO NORDISK A/S
To: BIOGENERIX AG
Reel/Frame 025744/0039 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2009
From: NEOSE TECHNOLOGIES, INC.
To: NOVO NORDISK A/S
Reel/Frame 022699/0109 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2008
From: JOHNSON, KARL; MOBASSERI, ALIAKBAR; BAI, XIAOMEI; KINEALY, KYLE
To: NEOSE TECHNOLOGIES, INC.
Reel/Frame 021938/0584 →